Current Phase: Grant Submission (invitation only): Dec. 14, 2016 - Jan. 30, 2017
Next Phase: Grant Review: Feb. 1-20, 2017
ENTELLIGENCE Young Investigator Program
ENTELLIGENCE is a program for basic science, translational, and clinical research in the field of cardiopulmonary medicine.
The program provides opportunities for individual young investigators to promote quality medical care and enhance patients' lives by supporting research in pulmonary hypertension (PH) related to expanding our knowledge of the pathways involved in pulmonary vascular pathobiology.
Sign Up For Reminder Alerts
All 2016-2017 Letter of Intent (LOI) applications have been evaluated by the ENTELLIGENCE Steering Committee, and selected LOI applicants have been invited to submit a full grant proposal. Each LOI was reviewed according to a number of criteria, including eligibility, applicant qualifications, potential for the applicant to develop as an independent researcher, quality of the applicant's mentor and environment, project impact, appropriateness for the program, and feasibility.
The ENTELLIGENCETM Young Investigator program is supported through an educational grant from Actelion Pharmaceuticals US, Inc.